Physician profile
Michael D Patterson
NPI 1891792248
$7,095.49
in general payments reported to CMS, 2019-2025
5 companies · $13.43 in 2025
The $13.43 reported for 2025 was less than what a typical Hospice and Palliative Medicine (Internal Medicine) provider received nationally (typical 2025 total: $77.77).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,765 · 2021: $31.07 · 2023: $23.98 · 2024: $263 · 2025: $13.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $263 · Food and Beverage: $23.98 · Education: $13.43.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $262.50 |
| Food and Beverage | $23.98 |
| Education | $13.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $6,748.45 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $262.50 | 2024 | Tecnis Simplicity, Veritas Vision System |
| Abbvie INC. | $55.05 | 2021-2023 | |
| Janssen Pharmaceuticals, INC | $16.06 | 2019 | |
| Travere Therapeutics, INC. | $13.43 | 2025 | Filspari |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Patterson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.